Abstract
Summary Allergic rhinitis is a worldwide health problem, which can greatly interfere with the quality of life of affected patients. Allergic conjunctivitis and asthma often accompany rhinitis. Unlike asthma, allergic rhinitis does not affect the physical activities of sufferers. However, rhinitis does impair the mental and social activities as much as any associated asthma. In view of the considerable adverse impact of allergic rhinitis on the life of affected individuals, treatment must be optimal. The efficacy of the range of available medications has been evaluated on the basis of scientific evidence, especially that derived from randomized controlled trials. From the collated information, guidelines have been formulated – the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. Drugs with confirmed efficacy (antihistamines, topical cromones and steroids) have been used to treat patients with intermittent or persistent allergic rhinitis. Patients should be treated with a stepwise approach, using increasingly powerful therapy for symptoms of increasing severity. It is necessary to emphasize that patients must be treated as an entity, so that not only the allergic rhinitis but also any accompanying conjunctivitis or asthma are treated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.